Dr Reddy's Laboratories rose 3.18% to Rs 4,031.85 at 14:45 IST on BSE with the stock extending prior sessions' 5.23% gains triggered by company announcing good Q1 results.
Meanwhile, the S&P BSE Sensex was up 434.04 points or 1.57% at 28,139.39.
On BSE, so far 39,136 shares were traded in the counter as against average daily volume of 17,593 shares in the past one quarter.
Shares of pharma company hit a high of Rs 4,058, which was also a record high for the stock. The stock hit a low of Rs 3,960 so far during the day. The stock had hit a 52-week low of Rs 2,711.90 on 11 August 2014.
Dr Reddy's Laboratories' consolidated net profit rose 13.67% to Rs 625.65 crore on 6.62% rise in total income to Rs 3770.25 crore in Q1 June 2015 over Q1 June 2014. Dr Reddy's Laboratories' earnings before interest, taxation, depreciation and amortization (EBITDA) rose 12% to Rs 990 crore in Q1 June 2015 over Q1 June 2014. EBITDA margin increased to 26.5% in Q1 June 2015 compared with 25.2% in Q1 June 2014. Gross profit margin increased by 1.8% to 61.1% in Q1 June 2015 compared with Q1 June 2014. The company announced results during market hours yesterday, 30 July 2015.
Powered by Capital Market - Live News
